Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy-Reference-Cited by-同舟云学术

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

Published:2021-04 Issue:4 Volume:74 Page:801-810
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Dietz Julia^ORCID,Di Maio Velia Chiara,de Salazar Adolfo,Merino Dolores,Vermehren Johannes,Paolucci Stefania,Kremer Andreas E.^ORCID,Lara Magdalena,Pardo Maria Rodriguez,Zoller Heinz,Degasperi Elisabetta,Peiffer Kai-Henrik,Sighinolfi Laura,Téllez Francisco,Graf Christiana,Ghisetti Valeria,Schreiber Jonas^ORCID,Fernández-Fuertes Elisa,Boglione Lucio,Muñoz-Medina Leopoldo,Stauber Rudolf^ORCID,Gennari William^ORCID,Figueruela Blanca,Santos Jesús,Lampertico Pietro,Zeuzem Stefan^ORCID,Ceccherini-Silberstein Francesca,García Federico,Sarrazin Christoph,Aghemo Alessio,Allice Tiziano,Andreoni Massimo,Angelico Mario,Baldanti Fausto,Barbaliscia Silvia,Bertoli Ada,Borghi Vanni,Calvaruso Vincenza,Cariti Giuseppe,Craxì Antonio,Francioso Simona,Perno Carlo Federico,Pozzoni Pietro,Toniutto Pier Luigi,Zazzi Maurizio,Pérez Ana Belén,Quilez Cristina,Alados Juan Carlos,Cabezas Joaquin,Ruiz-Tapiador Juan Ignacio Arenas,Jimenez Miguel,Pascasio-Acevedo Juan Manuel,Rodriguez Manuel Alberto Macias,Zabal Jose Miguel Rosales,Deltoro Miguel García,Sapiña Ana María Martinez,Fuentes Ana,Chueca Natalia,Berg Christoph P.,Herrmann Andreas,Stallmach Andreas,Port Kerstin,Katja Deterding M.,Wedermeyer Heiner,Cornberg Markus,Manns Michael P.,Moreno Christophe,Wiesch Julian Schulze zur,Piecha Felix,Lohse Ansgar,Siebler Jürgen,Kordecki Nikolaus,Magenta Lorenzo,Jäger Burkhard,Möller Hjördis,Heyne Renate,Beyer Tomas,Grunwald Stephan,Baumgarten Axels,Jägel-Guedes Eva,Schmidt Wolfgang

Funder

Deutsches Zentrum für Infektionsforschung

Publisher

Elsevier BV

Subject

Hepatology

Reference43 articles.

1. The importance of resistance to direct antiviral drugs in HCV infection in clinical practice;Sarrazin;J Hepatol,2016

2. Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens;Pawlotsky;Gastroenterology,2016

3. Patterns of resistance-associated substitutions in patients with chronic HCV infection following treatment with direct-acting antivirals;Dietz;Gastroenterology,2018

4. Long-term persistence of HCV NS5A resistance-associated substitutions after treatment with the HCV NS5A inhibitor, ledipasvir, without sofosbuvir;Wyles;Antivir Ther,2018

5. Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies;Di Maio;Liver Int,2017

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review;Expert Opinion on Pharmacotherapy;2024-08-12

2. Reply to „Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in DAA failure patients: an integrative analysis”;JHEP Reports;2024-08

3. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients;JHEP Reports;2024-07

4. Real‐life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir;Alimentary Pharmacology & Therapeutics;2024-05-02

5. Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C;Revista Española de Quimioterapia;2024-04-19